Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
NIHR Bioresource Rare Diseases, |
RCV000852195 | SCV000899884 | uncertain significance | Hereditary von Willebrand disease | 2019-02-01 | criteria provided, single submitter | research | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002509210 | SCV002819767 | uncertain significance | not specified | 2022-12-23 | criteria provided, single submitter | clinical testing | Variant summary: VWF c.7135C>T (p.Arg2379Cys) results in a non-conservative change to a highly conserved amino acid in the encoded protein sequence. Three of four in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 3.6e-05 in 251010 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. c.7135C>T has been reported in the literature in individuals affected with Von Willebrand Disease and Hemolytic Uremic Syndrome without evidence of causality and with other co-occurring variants (James_2007, Downes_2019, Haydock_2022). These reports do not provide unequivocal conclusions about association of the variant with Von Willebrand Disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. One submitter has provided a clinical-significance assessment for this variant to ClinVar after 2014 without evidence for independent evaluation, classifying the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as uncertain significance. |
Academic Unit of Haematology, |
RCV000086873 | SCV000119079 | not provided | not provided | no assertion provided | not provided |